|
[1]
|
J. W. Mink, “The Basal Ganglia: Focused Selection and Inhibi-tion of Competing Motor Programs,” Progress in Neurobiology, Vol. 50, No. 4, 1996, pp. 381-425.
doi:10.1016/S0301-0082(96)00042-1
|
|
[2]
|
J. P. Bolam, J. J. Hanley, P. A. Booth and M. D. Bevan, “Synaptic Organisation of the Basal Ganglia,” Journal of Anatomy, Vol. 196, No. 4, 000, pp. 527-542.
doi:10.1046/j.1469-7580.2000.19640527.x
|
|
[3]
|
J. W. Mink, “The Basal Ganglia and Involuntary movements: Impaired Inhibition of Competing Motor Patterns,” Archives of Neurology, Vol. 60, No. 10, 2003, pp. 1365-1368. doi:10.1001/archneur.60.10.1365
|
|
[4]
|
C. D. Marsden, J. A. Obeso, J. J. Zarranz and A. E. Lang “The Anatomical Basis of Symptomatic Hemidystonia.” Brain; Vol. 108, No. Pt. 2, 1985, pp. 463-483.
doi:10.1093/brain/108.2.463
|
|
[5]
|
K. P. Bhatia and C. D. Marsden, “The Behavioural and Motor Consequences of Focal Lesions of the Basal Ganglia in Man,” Brain, Vol. 117, No. 4, 1994, pp. 859-876.
doi:10.1093/brain/117.4.859
|
|
[6]
|
M. Hallett, “Overview of Human Tremor Physiology,” Movement Disorders, Vol. 13, Suppl. 3, 1998, pp. 43-48.
doi:10.1002/mds.870131308
|
|
[7]
|
J. Jankovic and K. M. Shannon, “Movement Disorders,” In: W. G. Bradley, R. B. Daroff, G. M. Fenichel and J. Jankovic, Ed., Neurology in Clinical Practice, 5th Edition, Butterworth Heinemann Elsevier, Philadelphia, 2008, p. 2081.
|
|
[8]
|
B. L. Schlaggar and J. W. Mink, “Movement Disorders in Children,” Pediatric Review, Vol. 24, No. 2, 2003, pp. 39-51. doi:10.1542/pir.24-2-39
|
|
[9]
|
R. P. Simon, D. A. Greenberg and M. J. Aminoff, “Movement Disorders,” In: R. P. Simon, D. A. Greenberg and M. J. Aminoff, Ed., Clinical Neurology, 7 Edition, McGraw Hill, New York, 2009.
|
|
[10]
|
J. F. Leckman, “Phenomenology of Tics and Natural History of Tic Disorders,” Brain Development, Vol. 25, Suppl. 1, 2003, pp. S24-28.
doi:10.1016/S0387-7604(03)90004-0
|
|
[11]
|
D. Shprecher and R. Kurlan, “The Management of Tics,” Movement Disorders, Vol. 24, No. 1, 2009, pp. 15-24. doi:10.1002/mds.22378
|
|
[12]
|
J. M. Dooley, “Tic Disorders in Childhood,” Seminars in Pediatric Neurology, Vol. 13, No. 4, 2006, pp. 231-242.
doi:10.1016/j.spen.2006.09.004
|
|
[13]
|
D. S. Wolf and H. S. Singer, “Pediatric Movement Disorders: An Update,” Current Opinion in Neurology, Vol. 21, No. 4, 2008, pp. 491-496.
doi:10.1097/WCO.0b013e328307bf1c
|
|
[14]
|
M. R. Delgado and A. L. Albright, “Movement Disorders in Children: Definitions, Classifications, and Grading Systems,” Journal of Child Neu-rology, Vol. 18, Suppl. 1, 2003, pp. S1-8.
|
|
[15]
|
T. M. O’Shea, “Diagnosis, Treatment, and Prevention of Cerebral Palsy,” Clinical Obstetrics and Gynecology, Vol. 51, No. 4, 2008, pp. 816-828.
doi:10.1097/GRF.0b013e3181870ba7
|
|
[16]
|
G. Zorzi, F. Zibordi, B. Garavaglia and N. Nardocci, “Early Onset Primary Dystonia,” European Journal of Paediatric Neurology, Vol. 13, No. 6, 2009, pp. 488-492.
doi:10.1016/j.ejpn.2008.12.001
|
|
[17]
|
F. Cardoso, K. Seppi, K. J. Mair, G. K. Wenning and W. Poewe, “Seminar on Choreas,” Lancet Neurology, Vol. 5, No. 7, 2006, pp. 589-602.
doi:10.1016/S1474-4422(06)70494-X
|
|
[18]
|
I. Korn-Lubetzki and A. Brand, “Sydenham’s Chorea in Jerusalem: Still Present,” Israel Medical Association Journal, Vol. 6, No. 8, 2004, pp. 460-452.
|
|
[19]
|
I. Korn-Lubetzki, A. Brand and I. Steiner, “Recurrence of Sydenham’s Chorea: Implications for Pathogenesis,” Archives of Neurology, Vol. 61, No. 8, 2004, pp. 1261-1264.
doi:10.1001/archneur.61.8.1261
|
|
[20]
|
Centers for Disease Control and Prevention (CDC), “Prevalence of diagnosed Tourette Syndrome in Persons Aged 6-17 Years United States, 2007,” Morbidity and Mortality Wkeekly Report, Vol. 58, No. 21, 2008, pp. 581-585.
|
|
[21]
|
J. F. Leckman, M. H. Bloch, L. Scahill and R. A. King, “Tourette Syndrome: The Self Under Siege,” Journal of Child Neurology, Vol. 21, No. 8, 2006, pp. 642-649.
doi:10.1177/08830738060210081001
|
|
[22]
|
R. Jin, R. Y. Zheng, W. W. Huang, H. Q. Xu, B. Shao, H. Chen and L. Feng, “Epidemiological Survey of Tourette Syndrome in Children and Adolescents in Wenzhou of P. R. China,” European Journal of Epidemiology, Vol. 20, No. 11, 2005, pp. 925-627.
doi:10.1007/s10654-005-2953-z
|
|
[23]
|
E. K. Tan, S. Y. Lum and K. M. Prakash, “Clinical Features of Childhood Onset Essential Tremor,” European Journal of Neurology, Vol. 13, No. 12, 2006, pp. 1302-1305. doi:10.1111/j.1468-1331.2006.01471.x
|
|
[24]
|
S. K. Das, T. K. Banerjee, T. Roy, D. K. Raut, A. Chau- dhuri and A. Hazra, “Prevalence of Essential Tremor in the City of Kolkata, India: A House-to-House Survey,” European Journal of Neurology, Vol. 16, No. 7, 2009, pp. 801-807. doi:10.1111/j.1468-1331.2009.02589.x
|
|
[25]
|
J. Jankovic, J. Madisetty and K. D. Vuong, “Essential Tremor among Child-ren,” Pediatrics, Vol. 114, No. 5, 2004, pp. 1203-1205. doi:10.1542/peds.2004-0031
|
|
[26]
|
S. Keller and L. S. Dure “Tremor in Childhood,” Seminar in Pediatric Neurology, Vol. 16, No. 2, 2009, pp. 60-70. doi:10.1016/j.spen.2009.03.007
|
|
[27]
|
A. M. Hibbs and S. A. Lorch, “Metoclopramide for the Treatment of Gastroesophageal Reflux Disease in Infants: A Systematic Review,” Pediatrics, Vol. 118, No. 2, 2006, pp. 746-752. doi:10.1542/peds.2005-2664
|
|
[28]
|
A. Alvarez-Díaz, E. Hilario, F. G. de Cerio, A. Valls-i-Soler and F. J. Alvarez-Díaz, “ Hypoxic-Ischemic Injury in the Immature Brain: Key Vascular and Cellular Players,” Neonatology, Vol. 92, No. 4, 2007, pp. 227-235.
doi:10.1159/000103741
|
|
[29]
|
C. McLean and D. Ferriero, “Mechanisms of Hypoxic- Ischemic Injury in the Term Infant,” Seminar in Perinatology, Vol. 28, No. 6, 2004, pp. 425-432.
doi:10.1053/j.semperi.2004.10.005
|
|
[30]
|
S. Khot and D. L. Tirschwell, “Long-Term Neurological Complications after Hypoxic-Ischemic Encephalopathy,” Seminar in Neurology, Vol. 26, No. 4, 2006, pp. 422-431.
doi:10.1055/s-2006-948323
|
|
[31]
|
J. Menkes, “Heredodegenerative Diseases,” In: J. H. Menkes, H. B. Sarnat and B. L. Maria, Eds., Child Neurolog, 7th Edition, Lippincott Williams & Wil-kins, Philadelphia, 2005, p. 163.
|
|
[32]
|
J. H. Menkes, W. R. Wilcox, “Inherited Metabolic Diseases of the Nervous System,” In: J. H. Menkes, H. B. Sarnat and B. L. Maria, Eds., Child Neurology, 7th Edition, Lippincott Williams & Wilkins, Phila-delphia, 2005, p. 29.
|
|
[33]
|
E. Fernandez-Alvarez and J. Aicardi, (Eds.), “Movement Disorders in Children,” MacKeith Press, London, 2001, p. 19.
|
|
[34]
|
J. H. Menkes and H. B. Sarnat, “Perinatal Asphyxia and Trauma,” J. H. Menkes, H. B. Sarnat and B. L. Maria, Eds., Child Neurology, 7th Edition, Lippincott Williams & Wilkins, Philadelphia, 2005, p. 367.
|
|
[35]
|
R. D. Folkerth, “Neuropathologic Substrate of Cerebral palsy,” Jour-nal of Child Neurology, Vol. 20, No. 12, 2005, pp. 940-949. doi:10.1177/08830738050200120301
|
|
[36]
|
M. V. Johnston and A. H. Hoon Jr., “ Possible Mechanisms in Infants for Selective Basal Ganglia Damage from Asphyxia, Kernicterus, or Mitochondrial Encephalopathies,” Journal of Child Neurology, Vol. 15, No. 9, 2000, pp. 588-591. doi:10.1177/088307380001500904
|
|
[37]
|
C. Boichot, P. M. Walker, C. Durand, M. Grimaldi, S. Chapuis, J. B. Gouyon and F. Brunotte, “Term Neonate Prognoses after Perinatal Asphyxia: Contributions of MR Imaging, MR Spectroscopy, Relaxation Times, and Apparent Diffusion Coefficients,” Radiology, Vol. 239, No. 3, 2006, pp. 839-848. doi:10.1148/radiol.2393050027
|
|
[38]
|
S. M. Shapiro, “Bilirubin Toxicity in the Developing Ner- vous System,” Pediatric Neurology, Vol. 29, No. 5, 2003, pp. 410-421. doi:10.1016/j.pediatrneurol.2003.09.011
|
|
[39]
|
J. F. Watchko, “Kernicterus and the Molecular Mechanisms of Bilirubin-Induced CNS Injury in Newborns,” Neuromolecular Medecine, Vol. 8, No. 4, 2006, pp. 513- 529. doi:10.1385/NMM:8:4:513
|
|
[40]
|
D. Martino and G. Giovannoni, “Antibasal Ganglia Antibodies and Their Relevance to Movement Disorders”. Current Opinion in Neurology, Vol. 17, No. 4, 2004, pp. 425-432. doi:10.1097/01.wco.0000137532.76491.19
|
|
[41]
|
S. T. Shulman, “Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococci (PANDAS): Update,” Current Opinion in Pediatrics, Vol. 21, No. 1, 2009, pp. 127-130. doi:10.1097/MOP.0b013e32831db2c4
|
|
[42]
|
R. C. Dale, A. J. Church, R. A. Surtees, A. J. Lees, J. E. Adcock, B. Harding, B. G. Neville, G. Giovannoni, “Encephalitis Lethargica Syndrome: 20 New Cases and Evidence of Basal Ganglia Autoimmunity,” Brain, Vol. 127, No. Pt1, 2004, pp. 21-33. doi:10.1093/brain/awh008
|
|
[43]
|
M. W. Kullnat and R. P. Morse, “Choreoathetosis after Herpes Simplex Encephalitis with Basal Ganglia Invol- vement on MRI,” Pediatrics, Vol. 121, No. 4, 2008, pp. e1003-1007. doi:10.1542/peds.2007-0813
|
|
[44]
|
S. Ashwal, B. S. Russman, P. A Blasco, G. Miller, A. Sandler, M. Shevell and R. Stevenson, Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society, “Practice Parameter: Diagnostic Assessment of the child with cerebral Palsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society,” Neurology, Vol. 62, No. 6, 2004, pp. 851-863.
|
|
[45]
|
A. H. Hoon Jr., E. M. Reinhardt, R. I. Kelley, S. N. Breiter, D. H. Morton, S. B. Naidu, M. V. Johnston, “Brain Magnetic Resonance Imaging in Suspected Extrapyramidal Cerebral Palsy: Observations in Distinguishing Genetic-Metabolic from Acquired Cause,” Journal of Pediatrics, Vol. 131, No. 2, 1997, pp. 240-245.
doi:10.1016/S0022-3476(97)70160-4
|
|
[46]
|
M. V. Johnston and A. H. Hoon Jr., “Cerebral Palsy,” Neuromolecular Medecine, Vol. 8, No. 4, 2006, pp. 435- 450. doi:10.1385/NMM:8:4:435
|
|
[47]
|
B. S. Russman and S. Ashwal, “Evaluation of the Child with Cerebral Palsy,” Seminar in Pediatric Neurology, Vol. 11, No. 1, 2004, pp. 47-57.
doi:10.1016/j.spen.2004.01.007
|
|
[48]
|
K. Gkoltsiou, M. Tzoufi, S. Counsell, M. Rutherford and F. Cowan, “ Serial Brain MRI and Ultrasound Findings: Relation to Gestational Age, Bilirubin Level, Neonatal Neurologic Status and Neurodevelopmental Outcome in Infants at Risk of kernicterUs,” Early Human Development, Vol. 84, No. 12, 2008, pp. 829-838.
doi:10.1016/j.earlhumdev.2008.09.008
|
|
[49]
|
D. L. Gilbert, “Drug-Induced Movement Disorders in Children,” Annals of the New York Academy of Sciences, Vol. 1142, 2008, pp. 72-84. doi:10.1196/annals.1444.005
|
|
[50]
|
E. Y. Uc and R. L. Rod-nitzky, “Childhood Dystonia,” Seminar in Pediatric Neurology, Vol. 10, No. 1, 2003, pp. 52-61. doi:10.1016/S1071-9091(02)00010-4
|
|
[51]
|
C. U. Correll and E. M. Schenk, “Tardive dyskinesia and new antipsychotics,” Cur-rent Opinion in Psychiatry, Vol. 21, No. 2, 2008, pp. 151-156.
doi:10.1097/YCO.0b013e3282f53132
|
|
[52]
|
C. U. Correll and J. M. Kane, “One-Year Incidence Rates of Tardive Dyskinesia in Children and Adolescents Treated with Second-Generation Antipsychotics: A Systematic Review,” Journal of Child and Adolescent Psychopharmacology, Vol. 17, No. 5, 2007, pp. 647-656.
doi:10.1089/cap.2006.0117
|
|
[53]
|
N. Gordon, “Sydenham’s Chorea and Its Complications Affecting the Nervous System,” Brain and Development, Vol. 31, No. 1, 2009, pp. 11-14.
doi:10.1016/j.braindev.2008.05.001
|
|
[54]
|
R. Kurlan, D. Johnson, E. L. Kaplan and the Tourette Syndrome Study Group, “Streptococcal Infection and Exacerbations of Childhood Tics and Obsessive-Compulsive Symptoms: A Prospective Blinded Cohort Study,” Pediatrics, Vol. 121, No. 6, 2008, pp. 1188-1197.
doi:10.1542/peds.2007-2657
|
|
[55]
|
S. E. Swedo, H. L. Leonard, M. Garvey, B. Mittleman, A. J. Allen, S. Perlmutter, L. Lougee, S. Dow, J. Zamkoff, and B. K. Dubbert, “Pediatric Autoimmune Neuropsychi- atric Disorders Associated with Streptococcal Infections: Clinical Description of the First 50 Cases,” American Journal of Psychiatry, Vol. 155, No. 2, 1998, pp. 2264- 2371.
|
|
[56]
|
V. Gabbay, B. J. Coffey, J. S. Babb, L. Meyer, C. Wach- tel, S. Anam and B. Rabinovitz, “Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus: Comparison of Diagnosis and Treatment in the Community and at a Specialty Clinic,” Pediatrics, Vol. 122, No. 3, 2008, pp. 273-278.
doi:10.1542/peds.2007-1307
|
|
[57]
|
S. J. Hayflick, S. K. Westa-way, B. Levinson, B. Zhou, M. A. Johnson, K. H. Ching and J. Gitschier, “Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome,” New England Journal of Med-icine, Vol. 348, No. 1, 2003, pp. 33-40.
doi:10.1056/NEJMoa020817
|
|
[58]
|
A. Machado, H. F. Chien, M. M. Deguti, E, Can?ado R. S. Azevedo, M. Scaff and E. R. Barbosa, “Neurological Ma- nifestations in Wilson’s Disease: Report of 119 Cases,” Movement Disorder, Vol. 21, No. 2, 2006, pp. 2192-2196.
doi:10.1002/mds.21170
|
|
[59]
|
J. Klepper and B. Leiendecker, “GLUT1 Deficiency Syndrome: 2007 Update,” Developmental Medicine and Child Neurology, Vol. 49, No. 9, 2007, pp. 707-716.
doi:10.1111/j.1469-8749.2007.00707.x
|
|
[60]
|
J. W. Mink and L. S. Dure, “Paroxysmal Movement Disorders in Childhood,” In: B. L. Maria, Ed., Current Management in Child Neurology, 3rd Edition, BC Decker, Hamilton (Canada), 2005, p. 427.
|
|
[61]
|
N. Kabaku? and A. Kurt, “Sandifer Syndrome: a continuing Problem of Misdiagnosis,” Pediatric International, Vol. 48, No. 6, 2006, pp. 622-625.
doi:10.1111/j.1442-200X.2006.02280.x
|
|
[62]
|
A. S. Golden, S. R. Haut and S. L. Moshé, “Nonepileptic uses of Antiepileptic Drugs in Children and Adolescents,” Pediatric Neurology, Vol. 34, No. 6, 2006, pp. 421-432.
doi:10.1016/j.pediatrneurol.2005.08.017
|
|
[63]
|
F. J. Jiménez-Jiménez and P. J. García-Ruiz, “Pharmacological Options for the Treatment of Tourette’s Disorder,” Drugs, Vol. 61, No. 15, 2001, pp. 2207-2220.
|
|
[64]
|
M. A. Gerber, R. S. Baltimore, C. B. Eaton, M. Gewitz, A. H. Rowley, S. T. Shulman and K. A. Taubert, “Prevention of Rheumatic Fever and Diag-nosis and Treatment of Acute Streptococcal Pharyngitis: A Scientific Statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Com-mittee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Trans- lational Biology, and the Interdisciplinary Council on Quality of Care an
|
|
[65]
|
J. Rice and M. C. Waugh, “Pilot Study on Trihexyphenidyl in the Treatment of Dystonia in Children with Cerebral Palsy,” Journal of Child Neurology, Vol. 24, No. 2, 2009, pp. 176-182. doi:10.1177/0883073808322668
|
|
[66]
|
M. M. Qasaymeh and J. W. Mink, “New Treatments for Tic Disorders,” Current Treatment Options in Neurology, Vol. 8, No. 6, 2006, pp. 465-473.
doi:10.1007/s11940-006-0036-4
|
|
[67]
|
R. Nicolson, B. Craven-Thuss, J. Smith, B. D. McKinlay and F. X. Castellanos, “A Randomized, Double-Blind, Placebo-Controlled Trial of Metoclopramide for the Treatment of Tourette’s Disorder,” Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 44, No. 7, 2005, pp. 640-646.
doi:10.1097/01.chi.0000163279.39598.44
|
|
[68]
|
R. J. Stephens, C. Bassel and P. Sandor, “Olanzapine in the Treatment of Aggression and Tics in Children with Tourette’s Syndrome: A Pilot Study,” Journal of Child and Adolescent Psychopharmacology, Vol. 14, No. 2, 2004, pp. 255-266. doi:10.1089/1044546041648959
|
|
[69]
|
G. R. Gaffney, P. J. Perry, B. C. Lund, K. A. Bever-Stille, S. Arndt and S. Kuper-man, “Risperidone versus Clonidine in the Treatment of Children and Adolescents with Tourette’s Syndrome,” Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 41, No. 3, 2002, pp. 330- 336. doi:10.1097/00004583-200203000-00013
|
|
[70]
|
Tourette’s Syndrome Study Group, “Treatment of ADHD in Children with Tics: A Randomized Controlled Trial,” Neurology, Vol. 58, No. 4, 2002, pp. 527-536.
|
|
[71]
|
M. Vidailhet, L. Vercueil, J. L. Houeto, P. Krystkowiak, C. Lagrange, J. Yelnik, E. Bardinet, A. L. Benabid, S. Navarro, D. Dormont, S. Grand, S. Blond, C. Ardouin, B. Pillon, K. Dujardin, V. Hahn-Barma, Y. Agid, A. Destée, P. Pollak and French SPIDY Study Group, “Bilateral, Pallidal Deep Brainstimulation in Primary Generalized Dystonia: A Prospective 3 Year Follow-Up Study,” Lancet Neurology, Vol. 6, No. 3, 2007, pp. :223-229.
|
|
[72]
|
W. A. Marks, J. Honeycutt, F. Acosta and M. Reed, “Deep Brain Stimulation for Childhood onset Dystonias at Cook Children’s Medical Center, a Community Based Pediatric Hospital,” Semiar in Pediatric Neurology, Vol. 16, No. 2, 2009, pp. 90-98.
doi:10.1016/j.spen.2009.04.001
|
|
[73]
|
D. Servello, M. Porta, M. Sassi, A. Brambilla and M. M. Robertson, “Deep Brain Stimu-lation in 18 Patients with Severe Gilles de la Tourette Syndrome Refractory to Treatment: The Surgery and Stimulation,” Journal of Neurology Neurosurgery and Psychiatry, Vol. 79, No. 2, 2008, pp. 136-142. doi:10.1136/jnnp.2006.104067
|
|
[74]
|
R. J. Maciunas, B. N. Maddux, D. E. Riley, C. M. Whitney, M. R. Schoenberg, P. J. Ogrocki, J. M. Albert and D. J. Gould, “Prospective Randomized Double-Blind Trial of Bilateral Thalamic Deep Brain Stimulation in Adults with Tourette Syndrome,” Journal of Neurosurgery, Vol.107, No. 5, 2007 pp. 1004-1014.
doi:10.3171/JNS-07/11/1004
|
|
[75]
|
J. Shahed, J. Poysky, C. Kenney, R. Simpson and J. Jankovic, “GPi Deep Brain Stimu-lation for Tourette Syndrome Improves Tics and Psychiatric Comorbidities,” Neurology, Vol. 68, No. 2, 2007, pp 159-160.
doi:10.1212/01.wnl.0000250354.81556.90
|